Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorLahmer, Tobias
dc.contributor.authorBesson, Caroline
dc.contributor.authorSalmanton-García, Jon
dc.contributor.authorMarchesi, Francesco
dc.contributor.authorEl-Ashwah, Shaimaa
dc.contributor.authorNucci, Marcio
dc.contributor.authorJiménez, Moraima
dc.contributor.authorCabirta, Alba
dc.date.accessioned2024-06-07T10:18:11Z
dc.date.available2024-06-07T10:18:11Z
dc.date.issued2024-06
dc.identifier.citationLahmer T, Salmanton-García J, Marchesi F, El-Ashwah S, Nucci M, Besson C, et al. Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey. Infection. 2024 Jun;52(3):1125–1141.
dc.identifier.issn1439-0973
dc.identifier.urihttps://hdl.handle.net/11351/11566
dc.descriptionUCI; COVID-19; Neoplàsies hematològiques
dc.description.sponsorshipOpen Access funding enabled and organized by Projekt DEAL. EPICOVIDEHA has received funds from Optics COMMIT (COVID-19 Unmet Medical Needs and Associated Research Extension) COVID-19 RFP program by GILEAD Science, United States (Project 2020-8223).
dc.language.isoeng
dc.publisherSpringer
dc.relation.ispartofseriesInfection;52(3)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectSang - Malalties - Epidemiologia
dc.subjectCOVID-19 (Malaltia) - Epidemiologia
dc.subjectEnquestes
dc.subjectMalalts en estat crític
dc.subject.meshCoronavirus Infections
dc.subject.meshHematologic Neoplasms
dc.subject.meshSurveys and Questionnaires
dc.subject.meshCritical Illness
dc.titleNeed for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s15010-023-02169-7
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsneoplasias hematológicas
dc.subject.decsencuestas y cuestionarios
dc.subject.decsenfermedad crítica
dc.relation.publishversionhttps://doi.org/10.1007/s15010-023-02169-7
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Lahmer T] Medizinische Klinik II, Klinikum rechts der Isar, TU München, Munich, Germany. [Salmanton García J] Faculty of Medicine, and University Hospital Cologne, Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany. Faculty of Medicine, University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University of Cologne, Cologne, Germany. German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany. [Marchesi F] Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. [El Ashwah S] Oncology Center, Mansoura University, Mansoura, Egypt. [Nucci M] Federal University of Rio de Janeiro, Rio de Janeiro, Brazil. [Besson C] Centre Hospitalier de Versailles, Le Chesnay, France. Université Paris-Saclay, UVSQ, Inserm, Équipe “Exposome et Hérédité”, CESP, Villejuif, France. [Jiménez M] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Cabirta A] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid38388854
dc.identifier.wos001183232800001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Portada del document

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple